Home › Funds › Venrock Adviser, LLC › ZURA
Venrock Adviser, LLC position in ZURA
ZURA BIO LTD · Health Care
Venrock Adviser, LLC reported holding 6,434,990 shares of ZURA (ZURA BIO LTD) in its Q3 2026 13F filing — a position valued at US$26.8M, representing 1.30% of its reported portfolio and ranking #21 among its reported holdings. Venrock Adviser, LLC has disclosed ZURA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Venrock Adviser, LLC's ZURA position evolved
Venrock Adviser, LLC first disclosed a stake in ZURA in Q2 2024 at 6,023,166 shares (US$21.1M). The position peaked in Q1 2026 at 6,434,990 shares, worth US$38.3M. Across 10 filings, Venrock Adviser, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 6,434,990 shares valued at US$26.8M. Notable position changes include a 66% trim in Q3 2024 (shares fell 38% over the following quarter), a 148% increase in Q1 2025 (shares fell 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 6.02M | $21.08M | New |
| Q3 2024 | 2.02M | $8.21M | Reduce |
| Q4 2024 | 2.02M | $5.06M | Hold |
| Q1 2025 | 5.02M | $6.48M | Add |
| Q2 2025 | 4.63M | $4.86M | Reduce |
| Q3 2025 | 4.63M | $20.05M | Hold |
| Q4 2025 | 5.35M | $28.01M | Add |
| Q1 2026 | 6.43M | $38.29M | Add |
| Q2 2026 | 6.43M | $37.97M | Hold |
| Q3 2026 | 6.43M | $26.77M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZURA and 13F data
ZURA (ZURA BIO LTD) is a Health Care company. 42 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$39.3M), MPM BioImpact LLC (US$18.5M), GREAT POINT PARTNERS LLC (US$17.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZURA
- MONTANOVA CAPITAL, LLC 9.44M sh · $39.28M · Q3 2026
- MPM BioImpact LLC 4.45M sh · $18.51M · Q3 2026
- GREAT POINT PARTNERS LLC 4.08M sh · $16.96M · Q3 2026
- Commodore Capital LP 3.25M sh · $13.52M · Q3 2026
- Saturn V Capital Management LP 2.03M sh · $8.46M · Q3 2026
- Vestal Point Capital, LP 1.86M sh · $7.74M · Q3 2026
- Foresite Capital Management VI LLC 1.76M sh · $7.31M · Q3 2026
- QVT Financial LP 1.67M sh · $6.94M · Q3 2026
- Squadron Capital Management LLC 1.20M sh · $4.99M · Q3 2026
- Ikarian Capital, LLC 1.02M sh · $4.24M · Q3 2026
- Blue Owl Capital Holdings LP 735.00K sh · $3.06M · Q3 2026
- EcoR1 Capital, LLC 679.72K sh · $2.83M · Q3 2026
More on Venrock Adviser, LLC
FAQ
How long has Venrock Adviser, LLC held ZURA?
Venrock Adviser, LLC has disclosed ZURA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Venrock Adviser, LLC's current position in ZURA?
As of Q3 2026, Venrock Adviser, LLC holds 6.43M shares of ZURA (ZURA BIO LTD), valued at $26.77M, representing 1.30% of its reported portfolio and ranking #21.
Has Venrock Adviser, LLC been buying or selling ZURA?
In the latest 13F filing (Q3 2026), Venrock Adviser, LLC held unchanged its position in ZURA. The position peaked in Q1 2026 at 6.43M shares.
Which other funds hold ZURA?
Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, MPM BioImpact LLC, GREAT POINT PARTNERS LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.